SRAX Inc. (NASDAQ: SRAX) Sells Remaining MD Stake For $8

New Post Public Reply Private Reply Replies (0) Message Board
NetworkNewsWire
218
SRAX Inc. (NASDAQ: SRAX) Sells Remaining MD Stake For $8 Million, Focused on Growing SaaS Data Management Investor Platform

- SRAX sells remaining MD ownership stake for $8 million
- MD sale allows SRAX to focus on rapid growth of Sequire platform
- Sequire unlocks big data investor insights for public companies
- Sequire revenue grew 29% year-over-year for Q2 2020, user base doubled to one million users during Q3 2020

SRAX (NASDAQ: SRAX), a financial technology company that unlocks data and insights for publicly traded companies through Sequire, its SaaS platform, has recently sold its remaining stake in its MD healthcare vertical for $8 million.

SRAX’s final divestment in MD represents the latest in a series of strategic moves that are further solidifying SRAX’s position in the investment industry. Along with spinning off its proprietary data-based BIGtoken platform into its own private company, SRAX has also acquired LD Micro, a leading data and event company serving the small and micro-cap space that provides exclusive information on micro-cap North American stocks.

“Our Sequire platform is rapidly growing and we are focused on the continued expansion of this business,” said SRAX founder and CEO Christopher Miglino (https://nnw.fm/vcJX4). “We believe that selling the MD ownership stake at this time reinforces our goal of being 100% focused on providing our platform and services to public companies. This capital will be effective in helping us accelerate growth. This asset currently sits on our balance sheet with a zero basis, so this capital will go directly to improving our balance sheet. This transaction combined with moving Bigtoken to its own public company brings clarity to our mission going forward.”

Sequire’s suite of tools allows public companies to unlock the power of investor data through warrant tracking, survey creation, events and roadshows, and customer relationship/resource management (“CRM”). Since its creation in 2019, the platform has grown rapidly, doubling its user base to over one million investors and traders across 91 public companies in just two months (https://nnw.fm/x9KS4) in addition to posting Q2 earnings that showed a 29% increase in year-over-year revenue. The acquisition of LD Micro is expected to further accelerate the adoption of Sequire, paving a new road forward for both companies.

“The platform is an absolute game-changer for public companies and their shareholders,” said LD Micro founder Chris Lahiji in recent statements (http://nnw.fm/ppRfl). “Both companies believe that one day executives will rely on Sequire the same way investors rely on Bloomberg.”

SRAX is on the Russell Microcap(R) Index in addition to being invited to the board of the Interactive Advertising Bureau (“IAB”) Data Policy Board. Through the creation of specialized tools that reveal core consumers and their characteristics, SRAX continues to leverage the growing demand for quantifiable and detailed consumer data across a wide range of industries.

For more information, visit the company’s website at www.SRAX.com.

Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

SRAX Inc. (SRAX) Stock Research Links

SRAX Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

US Foods Faces Major Strike Threat Over Driver Contracts

Updated Category News Views 84

Teamsters Prep for Possible Strike Against US Foods You can almost hear the union drums beating as 260 drivers from Teamsters Local 282 in New York gear up for what could be a major confrontation with US Foods. The message is loud and clear: pay us what we're worth, or watch your delivery chain grind to a halt. With unanimous approval to strike, this isn't just a...

Continue Reading
PMET Grows Mineral Assets at Shaakichiuwaanaan

Updated Category News Views 100

Resource Expansion at the Shaakichiuwaanaan Property You ever see a resource report that makes you do a double take? That's the vibe here with PMET's game-changing update on their Shaakichiuwaanaan property in Quebec. They've crunched the numbers at the Helios Caesium Zone and CV4 Pegmatite, and the results? A juicy increase in the grade, scale, and tonnage across three...

Continue Reading
GNSS Simulator Market: $425M by 2031, Key Insight

Updated Category News Views 118

GNSS Simulator Market: Gadgets Meet Growth A market that's been quietly bubbling away on the back burner is about to boil over: The GNSS Simulator Market, pegged at a neat $424.6 million by 2031. Yeah, it might be niche, but those in the know can't get enough of these satellite-signal replicators. Why GNSS Simulators are Crushing It There's a bunch of reasons why GNSS...

Continue Reading
EAF Relief Fund Launches After Learjet Disaster

Updated Category News Views 103

Mobilizing Aid: A Community in Crisis Not every day you wake up to a story that digs into your gut like this one. The folks at the Green Acres Mobile Home Community in Palm Beach County got dealt a raw deal. A Learjet crash shook their world apart on November 1st, leaving nine lives lost on that flight and sending hundreds of residents scrambling from their homes. It's a...

Continue Reading
RSPO RT2026 Tackles Indonesian Fires and Export Shifts

Updated Category News Views 15

Indonesia's Burning Questions There's been a lot of smoke—literally and figuratively—hanging over the palm oil industry in Indonesia this year. At the RSPO's Annual Roundtable on Sustainable Palm Oil (RT2026), attendees didn't shy away from addressing the harsh realities. In a year marked by rampant fires, thanks to the blistering El Niño, the RSPO showcased data...

Continue Reading
Staypineapple Backs Vets: A Heartwarming Initiative

Updated Category News Views 151

When Hotels Stand Up for Heroes Every now and then, you stumble upon a company doing something genuinely good, and Staypineapple's effort this November is one of those rare gems. In honor of Veterans Day, they're opening their checkbook to sling some real support to our nation’s vets and retired first responders. Their chosen cause? The American Humane Society's...

Continue Reading
HashKey and AMBR Unite to Push AI Frontiers in Finance

Updated Category News Views 34

Shaping the Future with AI Integration In the whirlwind of innovation, there's always the ones braving the frontier, pushing the very boundaries of what we deem possible. Today, it's HashKey Capital and AMBR joining forces, marching into uncharted financial territories. This partnership is more than just a signature on a piece of paper; it's a declaration—a commitment...

Continue Reading
Verismo's SynKIR-110: Revolutionizing CAR T Therapy?

Updated Category News Views 73

Clinical Stage Wonders and Bold Claims Here's the lowdown on the latest tale from Verismo Therapeutics, a name that's trying real hard to distinguish itself in the CAR T therapy arena. Grab a coffee, pal, and let's wade through what's cooking at their camp with the SynKIR™-110. Breaking Down the Science Jargon For you folks not knee-deep in immunotherapy, let me spell...

Continue Reading
Silvercorp Updates El Domo Budget Amid Challenges

Updated Category News Views 78

Budget Pains for Silvercorp's El Domo Project Folks, if you thought navigating the stock market was a minefield, try mining these days. Silvercorp Metals Inc. had to bump up its budget for the El Domo project in Ecuador—again. This time by $14.6 million. What's causing this fiscal heartache? Everything from rising diesel prices thanks to Ecuador playing games with...

Continue Reading
BD Appoints Bagnato as Peripheral Intervention Head

Updated Category News Views 13

A New Captain for BD's Peripheral Ship Time to pay attention, folks. Franklin Lakes just sent an interesting ripple through their workforce headlines, announcing Bridget Bagnato taking the reins as Worldwide President of BD's Peripheral Intervention division. Come November 16, this medical tech veteran, who's clocked over 27 years with BD, is set to start steering their...

Continue Reading

Top 5 Most Recently Viewed Articles

SEATOM Selected for NATO's Accelerator Programme Growth

Updated Category News Views 161

SEATOM's Selection for NATO's Accelerator Programme Today, SEATOM announced a significant milestone as it was chosen to participate in the NATO Defence Innovation Accelerator for the North Atlantic (DIANA) 2026 Challenge Programme. This prestigious selection underscores SEATOM's innovative approach to developing nuclear technology tailored for maritime and extreme...

Continue Reading
OpenAI's New Device Development Following $6.5 Billion Acquisition

Updated Category News Views 194

OpenAI Completes a Major Acquisition OpenAI has recently wrapped up a remarkable deal by acquiring Jony Ive's AI hardware startup, io Products, for a staggering $6.5 billion. This acquisition brings the design genius, renowned for his work at a major tech giant, into OpenAI's fold to help create a new generation of smart devices. Key Developments Post-Acquisition The...

Continue Reading
Opportunities for KinderCare Investors Amid Class Action News

Updated Category News Views 151

Opportunities for KinderCare Investors Robbins Geller Rudman & Dowd LLP has announced a significant opportunity for investors of KinderCare Learning Companies, Inc. (NYSE: KLC) who have experienced substantial losses. This is a pivotal moment for shareholders as they can now seek to lead a class action lawsuit against the company. Understanding the Class Action Lawsuit...

Continue Reading
Baltic Horizon Fund Sees Positive NAV Growth in May 2025

Updated Category News Views 128

Growth of Baltic Horizon Fund's NAV in May 2025 The Baltic Horizon Fund reported an increase in its net asset value (NAV) per unit, which rose to EUR 0.6757 at the close of May 2025. This figure represents a slight gain from the NAV of EUR 0.6740 recorded at the end of April 2025. The fund's overall net asset value reached EUR 97.0 million, up from EUR 96.8 million in the...

Continue Reading
Autolus Therapeutics Highlights CARLYSLE Trial Findings at ASH 2025

Updated Category News Views 239

Autolus Therapeutics Showcases CARLYSLE Trial Results Autolus Therapeutics plc (Nasdaq: AUTL), a biopharmaceutical leader in developing innovative T cell therapies, recently showcased promising preliminary data from the CARLYSLE trial, which focuses on severe refractory systemic lupus erythematosus (srSLE). The data were presented during a special session at a leading...

Continue Reading